TisagenlecleucelKymriahTecartusbrexucabtagén autoleucelYescartaAxicabtagén ciloleucelECOG Performance Statushematologic malignanciesmantle cell lymphomadiffuse large B-cell lymphoma+5 more
…red in 80.8%, brexucabtagén autoleucel(Tecartus ) in 11.5%, and Tisagenlecleucel(Kymriah ) in 7.7 % of patients. The median age was 67.5 years (…